Mucormycosis due to Lichtheimia (ex Absidia) corymbifera is a rare fungal infection, occurring most often in an environment of immune deficiency, rarely in an immunocompetent patient. It comes in different clinical forms, frequently misleading, hence the interest of a pathological and mycological examination that allows the diagnosis of certainty. The management of this condition should be introduced early because it affects the functional prognosis of the patient. In this study, the authors report a case of mucormycosis in a 10-year-old child, and with clinical immunocompetent less severe than the cases reported in the literature.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mycmed.2012.01.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Repurposing the non-steroidal anti-inflammatory drug diflunisal as an adjunct therapy with amphotericin B against mucoralean fungi.
J Med Microbiol
November 2024
Department of Microbial Biotechnology, Panjab University, Chandigarh 160014, India.
Mucormycosis is an aggressive, angioinvasive infection associated with high morbidity and mortality. The disease remains difficult to treat, with limited available antifungal drugs. Consequently, there is an urgent need to develop alternate therapeutics against mucormycosis.
View Article and Find Full Text PDFDisseminated Lichtheimia sp. Infection in a Buff-Headed Capuchin (Sapajus xanthosternos).
J Med Primatol
December 2024
Pathological Anatomy Sector (SAP), Federal Rural University of Rio de Janeiro (UFRuralRJ), Seropédica, Brazil.
A clinicopathologic picture caused by Lichtheimia sp. in a 33-year-old male Sapajus xanthosternos kept in a conservationist center is described. Acute apathy, vomiting, fever, and polydipsia were associated with pneumonia, enteritis, and gastritis presenting fibrinoid vasculitis containing hyphae.
View Article and Find Full Text PDFVenous intestinal ischemia of fungal origin as a cause of intestinal obstruction in immunocompromised patients: case report and literature review.
Gut Pathog
November 2024
Department of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá, D.C, Colombia.
Background: Mucormycosis is a highly lethal opportunistic fungal disease caused by ubiquitous molds of the order Mucorales, with Rhizopus, Lichtheimia and Mucor being the most common genera. This rare disease primarily affects immunocompromised patients, with presentations ranging from rhino-orbito-cerebral infections to disseminated mucormycosis with angioinvasion, leading to thrombosis and tissue infarction. Gastrointestinal mucormycosis is the least common clinical presentation and is believed to be secondary to spore ingestion.
View Article and Find Full Text PDFA rare intestinal mucormycosis caused by in a patient with diabetes: a case report.
Front Med (Lausanne)
October 2024
Department of Clinical Laboratory, The Affiliated Tai'an City Central Hospital of Qingdao University, Tai'an, Shandong, China.
Mucormycosis is an aggressive fungal disease. Gastrointestinal mucormycosis is rare, but its clinical symptoms lack specificity and mortality is high. Here, we report a case of intestinal mucormycosis caused by in a 65-year-old woman with diabetes mellitus.
View Article and Find Full Text PDFInvasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19.
Curr Microbiol
October 2024
Dr. HS Judge Institute of Dental Sciences and Hospital, Panjab University, Sector 25, Chandigarh, India.
Article Synopsis
- The COVID-19 pandemic led to approximately 6 million deaths worldwide, with a significant number caused by invasive fungal infections due to immune dysfunction in hospitalized patients, especially in ICUs.
- Common fungal pathogens affecting COVID-19 patients include Mucorales (like Rhizopus and Mucor), Aspergillus, and Candida, with a notably higher prevalence of mucormycosis in India linked to risk factors such as uncontrolled diabetes and prolonged steroid use.
- Diagnosing these infections is challenging due to limitations in current methods, making early detection and management crucial for improving patient outcomes and preventing high mortality rates.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!